Skip to main content
Armata Pharmaceuticals, Inc. logo

Armata Pharmaceuticals, Inc. — Investor Relations & Filings

Ticker · ARMP ISIN · US04216R1023 LEI · 549300QM1VCWH8KT0S21 US Manufacturing
Open in API
Filings indexed 1,011 across all filing types
Latest filing 2016-04-21 Capital/Financing Update
Country US United States of America
Listing US ARMP

About Armata Pharmaceuticals, Inc.

https://www.armatapharma.com/

Armata Pharmaceuticals, Inc. is a clinical-stage biotechnology company dedicated to developing pathogen-specific bacteriophage therapeutics to combat the global threat of antibiotic-resistant infections. The company's core focus is on creating precisely targeted, high-purity phage-based treatments for serious bacterial infections. This approach aims to provide an effective alternative to conventional antibiotics by eliminating harmful bacteria while preserving the patient's healthy microbiome. Armata's pipeline includes product candidates targeting multi-drug resistant pathogens, supported by its in-house cGMP manufacturing facility for clinical and commercial supply.

Recent filings

Filing Released Lang Actions
424B3
Capital/Financing Update Classification · 95% confidence The document is a Form 424B3 prospectus supplement filed pursuant to Rule 424(b)(3), which supplements a previously filed prospectus and incorporates by reference the company's Annual Report on Form 10-K for the fiscal year ended December 31, 2015. The text includes detailed information about the offering of common stock and references the 10-K report filed with the SEC. The document itself is a prospectus supplement related to a securities offering, not the full annual report. However, it incorporates the 10-K report by reference. Since the document is primarily a prospectus supplement related to a capital raising activity and stock offering, it fits best under the category of Capital/Financing Update (CAP). It is not the full 10-K report itself, nor is it a simple announcement of a report publication. The length and content indicate substantive information about the offering and related financial data. Therefore, the appropriate classification is CAP with high confidence.
2016-04-21 English
FORM 8-K
Board/Management Information Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content focuses on the resignation of a board member, Julian Kirk, and related events including a complaint filed against the company and board members. The key section is Item 5.02, which deals with departure and election of directors and officers. There is no financial data or detailed financial performance analysis, so it is not an Annual Report (10-K) or Interim Report (IR). It is not a proxy solicitation or voting results announcement. The document primarily announces changes in the company's board of directors and related management events. Therefore, the appropriate classification is Board/Management Information (MANG). The document length (8071 characters) supports it being a substantive filing rather than a brief announcement. Confidence is high given the clear focus on director resignation and related board matters.
2016-04-20 English
RANDAL J. KIRK SC 13D A NO. 1 4-15-2016 (AMPLIPHI BIOSCIENCES CORPORATION)
Major Shareholding Notification
2016-04-15 English
FORM 8-K
Regulatory Filings Classification · 100% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content describes the termination of a material definitive agreement (Exclusive Channel Collaboration Agreement) and related stock issuance and registration rights agreements. It does not contain financial statements or detailed financial performance data. The document is a regulatory announcement of a corporate event rather than a financial report or earnings release. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories.
2016-04-14 English
FORM 4 SUBMISSION
Director's Dealing
2016-04-12 English
FORM 3/A SUBMISSION
Director's Dealing
2016-04-12 English

Browse filings by year

24 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.